Dr Mark Kris breaks down the lazertinib-amivantamab data, noting that the combo shows benefit but fails to address key ...

Dr Kami Maddocks reflects on fresh data, such as the new epcoritamab combo approval, evolving CD19 sequencing data, and ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

Edward S. Cooper, MD, the American Heart Association’s first Black president, leaves behind an indelible mark on stroke ...

Growth hormone replacement therapy improves physical fitness, lifestyle habits, and quality of life in children with growth ...

Christmas traditions such as decorating a tree and singing not only lift spirits but also boost immunity by triggering immune ...

Menopause hormone therapy neither increases nor decreases the risk for dementia or mild cognitive impairment in ...

Semaglutide use is linked to fewer hospitalizations and fewer days in the hospital for patients with cardiovascular disease ...

An analysis of public videos of out-of-hospital cardiac arrests shows brief warning signs, seizure-like movements that may be ...

Patients’ fatigue levels before starting systemic cancer treatment predict their risk for severe or fatal side effects.

Among patients receiving treatment for glioblastoma, PPI use is associated with worse progression-free and overall survival, ...